Trial Profile
Retrospective study of Abiraterone Acetate + Prednisone Prior to Chemotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer (Mcrpc)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Nov 2018
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Prednisone (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 26 Nov 2018 New trial record
- 14 Nov 2018 Results presented at the 21st Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research